Ikonomidis, Ignatios
National and Kapodistrian University of Athens · University General Hospital Attikon
8 papers on CoChatORCID 0000-0001-8241-7886
Most cited papers
- Verified
Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment
Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., et al. (2020) · Journal of the American Heart Association
Diabetes Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 199
- Verified
Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
Lambadiari, V., Pavlidis, G., Kousathana, F., Varoudi, M., Vlastos, D., Maratou, E., Georgiou, D., Andreadou, I., Parissis, J., Triantafyllidi, H., et al. (2018) · Cardiovascular Diabetology
Diabetes Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 146
- Verified
Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study
Ikonomidis, I., Mazarakis, A., Papadopoulos, C., Patsouras, N., Kalfarentzos, F., Lekakis, J., Kremastinos, D. T., & Alexopoulos, D. (2007) · Journal of Hypertension
Bariatric Surgery and OutcomesCardiovascular Function and Risk Factors
Cited by 118
- Verified
Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality
Parissis, J. T., Rafouli-Stergiou, P., Mebazaa, A., Ikonomidis, I., Bistola, V., Nikolaou, M., Meas, T., Delgado, J., Vilas-Boas, F., Paraskevaidis, I., et al. (2012) · International Journal of Cardiology
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 58
- Verified
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
Koren, M. J., Descamps, O., Hata, Y., Hengeveld, E. M., Hovingh, G. K., Ikonomidis, I., Radu Juul Jensen, M. D., Langbakke, I. H., Martens, F. M. A. C., Søndergaard, A. L., et al. (2024) · The Lancet Diabetes & Endocrinology
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 43
- Verified
Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes
Lambadiari, V., Thymis, J., Kouretas, D., Skaperda, Z., Tekos, F., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., et al. (2021) · Antioxidants
Diabetes Treatment and ManagementAntioxidant Activity and Oxidative Stress
Cited by 42
- Verified
Semaglutide concurrently improves vascular and liver indices in patients with type 2 diabetes and fatty liver disease
Korakas, E., Kountouri, A., Pavlidis, G., Oikonomou, E., Vrentzos, E., Michalopoulou, E., Tsigkou, V., Katogiannis, K., Pliouta, L., Balampanis, K., et al. (2024) · Journal of the Endocrine Society
Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment
Cited by 18
- Verified
Effects of hormone replacement therapy on endothelial function, arterial stiffness and myocardial deformation in women with Turner syndrome
Peppa, M., Pavlidis, G., Mavroeidi, I., Katogiannis, K., Varoudi, M., Thymis, J., Kostelli, G., Vlastos, D., Plotas, P., Bamias, A., et al. (2021) · Journal of Hypertension
Cardiovascular Health and Disease PreventionMenopause: Health Impacts and Treatments
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free